Skip to main content
Gordon Downie, MD, Pulmonology, Mount Pleasant, TX

Gordon H Downie MD PhD

Critical Care Medicine, Pleural Disease


Director of Critical care and Interventional Pulmonology at Titus County Regional Medical Center

Join to view full profile
  • 301 W 18th StSte 101Mount Pleasant, TX 75455

  • Phone+1 903-572-9050

  • Fax+1 903-572-9051

Dr. Downie is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine, 1986 - 1989
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1986

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2007 - 2027
  • NC State Medical License
    NC State Medical License 2015 - 2025
  • GA State Medical License
    GA State Medical License 2017 - 2021
  • LA State Medical License
    LA State Medical License 2010 - 2021
  • MS State Medical License
    MS State Medical License 2020 - 2021
  • NY State Medical License
    NY State Medical License 1992 - 2021
  • SC State Medical License
    SC State Medical License 2016 - 2021
  • Internal Medicine
    National Board of Physicians and Surgeons Internal Medicine
  • Pulmonary Disease
    National Board of Physicians and Surgeons Pulmonary Disease
  • Join now to see all

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2011, 2013-2017
  • CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2011, 2013-2017
  • CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable
    bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer RoundtableDecember 3rd, 2025
  • bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
    bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025October 20th, 2025
  • bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025
    bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025October 7th, 2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: